FDA inspection
Fresenius Kabi Oncology Limited: FDA inspection ending Oct 10, 2023
FDA inspection 1220476 · Official Action Indicated (OAI) · Baddi
Key facts
| Inspection ID | 1220476 |
|---|---|
| Firm | Fresenius Kabi Oncology Limited |
| FEI number | 3006210232 |
| Address | Tehsil Nalagarh, Nalagarh Baddi Road |
| City | Baddi |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Oct 10, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data